Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 180

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity

Open access
Cillo, Anthony R., Cardello, Carly, Shan, Feng, Karapetyan, Lilit, Kunning, Sheryl, Sander, Cindy, Rush, Elizabeth, Karunamurthy, Arivarasan, Massa, Ryan C., Rohatgi, Anjali, Workman, Creg J., Kirkwood, John M., Bruno, Tullia C., Vignali, Dario A.A. · 2024 · Cell

Abstract

Summary Relatlimab (rela; anti-LAG3) plus nivolumab (nivo; anti-PD1) is safe and effective for treatment of advanced melanoma. We designed a trial (NCT03743766) where advanced melanoma patients received rela, nivo or rela+nivo to interrogate the immunologic mechanisms of rela+nivo. Analysis of biospecimens from this ongoing trial demonstrated that rela+nivo led to enhanced capacity for CD8+ T cell receptor signaling and altered CD8+ T cell differentiation, leading to heightened cytotoxicity despite retention of an exhaustion profile. Co-expression of cytotoxic/exhaustion signatures was driven by PRDM1, BATF, ETV7 and TOX. Effector function was upregulated in clonally expanded CD8+ T cells that emerged after rela+nivo. A rela+nivo intratumoral CD8+ T cell signature was associated with favorable prognosis. This intratumoral rela+nivo signature was validated in peripheral blood as an elevated frequency of CD38+TIM3+CD8+ T cells. Overall, we demonstrated that cytotoxicity can be enhanced despite the retention of exhaustion signatures, which will inform future therapeutic strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2024.06.036

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 180

Metadata

Authors
Cillo, A. R., Cardello, C., Shan, F., Karapetyan, L., Kunning, S., Sander, C., Rush, E., Karunamurthy, A., Massa, R. C., Rohatgi, A., Workman, C. J., Kirkwood, J. M., Bruno, T. C., & Vignali, D. A. A.
Venue
Cell
Publisher
Elsevier BV
Published
2024-08
Volume
187
Issue
16
Pages
4373-4388.e15
ISSN
0092-8674 (ISSN-L)
OpenAlex
W4401421807
Cited by
180
References
34
FWCI
27.62
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity. https://app.cochat.ai/papers/10.1016/j.cell.2024.06.036
The paper
Cillo, A. R., Cardello, C., Shan, F., Karapetyan, L., Kunning, S., Sander, C., Rush, E., Karunamurthy, A., Massa, R. C., Rohatgi, A., Workman, C. J., Kirkwood, J. M., Bruno, T. C., & Vignali, D. A. A. (2024). Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity. Cell. https://doi.org/10.1016/j.cell.2024.06.036

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.